These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1430970

  • 21. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
    Kobayashi T.
    Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antimicrobial resistance among Clostridium perfringens isolated from various sources in Thailand.
    Tansuphasiri U, Matra W, Sangsuk L.
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):954-61. PubMed ID: 16295551
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro activity of OPT-80 against Clostridium difficile.
    Ackermann G, Löffler B, Adler D, Rodloff AC.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2280-2. PubMed ID: 15155234
    [Abstract] [Full Text] [Related]

  • 26. Clostridium perfringens and Clostridium difficile in cooked beef sold in Côte d'Ivoire and their antimicrobial susceptibility.
    Kouassi KA, Dadie AT, N'Guessan KF, Dje KM, Loukou YG.
    Anaerobe; 2014 Aug; 28():90-4. PubMed ID: 24944124
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
    Tyrrell KL, Citron DM, Warren YA, Fernandez HT, Merriam CV, Goldstein EJ.
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibiotic resistance of Clostridium difficile isolates.
    Dworczyński A, Sokół B, Meisel-Mikołajczyk F.
    Cytobios; 1991 Aug; 65(262-263):149-53. PubMed ID: 1828756
    [Abstract] [Full Text] [Related]

  • 31. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
    Pituch H, Obuch-Woszczatyński P, Wultańska D, van Belkum A, Meisel-Mikołajczyk F, Łuczak M.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
    [Abstract] [Full Text] [Related]

  • 32. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M, Carera E, Palmgren AC, Nord CE.
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [Abstract] [Full Text] [Related]

  • 33. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.
    Clin Infect Dis; 2008 Jul 01; 47(1):56-62. PubMed ID: 18491964
    [Abstract] [Full Text] [Related]

  • 34. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
    Baines SD, O'Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, Kuijper EJ, Wilcox MH.
    J Antimicrob Chemother; 2008 Nov 01; 62(5):1046-52. PubMed ID: 18693234
    [Abstract] [Full Text] [Related]

  • 35. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L, Citron DM, Genheimer CW, Sigmon SF, Carman RJ, Lyerly DM, Goldstein EJ.
    Anaerobe; 2007 Nov 01; 13(3-4):114-20. PubMed ID: 17531516
    [Abstract] [Full Text] [Related]

  • 36. [Susceptibility of Clostridium difficile to metronidazole using the E-test: effect of the culture medium].
    Poilane I, Cruaud P, Rousseau JG, Torlotin JC, Collignon A.
    Pathol Biol (Paris); 1999 May 01; 47(5):515-8. PubMed ID: 10418031
    [Abstract] [Full Text] [Related]

  • 37. Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas.
    Norman KN, Scott HM, Harvey RB, Norby B, Hume ME.
    Foodborne Pathog Dis; 2014 Apr 01; 11(4):257-64. PubMed ID: 24320797
    [Abstract] [Full Text] [Related]

  • 38. [Isolation of toxigenic strains of Clostridium difficile and enterotoxin producing Bacteroides fragilis from fecal specimens of patients suspected of antibiotic associated diarrhoea].
    Pituch H, Leszczyński P, van Belkum A, Obuch-Woszczatyński P, Rouyan GS, Meisel-Mikołajczyk F.
    Med Dosw Mikrobiol; 1999 Apr 01; 51(1-2):59-66. PubMed ID: 10865431
    [Abstract] [Full Text] [Related]

  • 39. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.
    Dzink J, Bartlett JG.
    Antimicrob Agents Chemother; 1980 Apr 01; 17(4):695-8. PubMed ID: 7396460
    [Abstract] [Full Text] [Related]

  • 40. Comparison of supplemented Brucella agar and modified Clostridium difficile agar for antimicrobial susceptibility testing of Clostridium difficile.
    Kim GH, Kim J, Pai H, Kang JO.
    Ann Lab Med; 2014 Nov 01; 34(6):439-45. PubMed ID: 25368819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.